← Back to Patent Explorer
US5403923A Expired / Lapsed US ⏱️ 0.0 years remaining

6-0-methylerythromycin A derivatives

Assignee: Taisho Pharmaceutical Co Ltd
•
Filing: 1991-11-22
•
Granted: 1995-04-04
•
Expires: 2011-11-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract PCT No. PCT/JP91/01608 Sec. 371 Date May 20, 1993 Sec. 102(e) Date May 20, 1993 PCT Filed Nov. 22, 1991 PCT Pub. No. WO92/09614 PCT Pub. Date Jun. 11, 1992.This invention provides 6-O-methylerythromycin A derivatives represented by the following formula <IMAGE> (wherein R1 and R2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and A represents a nitrogen atom or a N->O group) and their pharmaceutically acceptable salts. The erythromycin A derivatives have a strong antimicrobial activity against Gram-negative bacteria and have a much stronger activity against Gram-positive bacteria than previously known compounds.

Inventors

  • 👤 Masato Kashimura
  • 👤 Toshifumi Asaka
  • 👤 Shigeo Morimoto
  • 👤 Katsuo Hatayama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 18:16
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 47 words
A 6-O-methylerythromycin A derivative represented by the following formula ##STR6## wherein R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and A represents a nitrogen atom or a N→O group or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 47 words
A 6-O-methylerythromycin A derivative represented by the following formula ##STR6## wherein R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and A represents a nitrogen atom or a N→O group or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

EP0184921A2 Cited
US4640910A Cited
US4742049A Cited
EP0248279B1 Cited
EP0321185A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-04-03 1998-10-03 1999-04-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-04-03 2002-10-03 2003-04-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-04-03 2006-10-03 2007-04-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag